Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Study validates Matritech's bladder cancer test

This article was originally published in Clinica

Executive Summary

Matritech's NMP22 BladderChek Test can detect cancers missed by cystoscopy - the reference standard used to diagnose bladder cancer, according to a study published in the Journal of the American Medical Association (JAMA) (February 16). The American Cancer Society says that approximately 13,000 people in the US will die from bladder cancer in 2005.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts